Accelerated atherosclerosis in saphenous vein bypass grafts: A spectrum of diffuse plaque instability

Progress in Cardiovascular Diseases

Volumn 44, Issue 6, 2002, Pages 437-448

  Safian, Robert D ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; ANGIOSCOPY; ARTERY GRAFT; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY; CORONARY ARTERY BYPASS GRAFT; ELECTRON BEAM TOMOGRAPHY; HUMAN; INTRAVASCULAR ULTRASOUND; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; REVIEW; SAPHENOUS VEIN GRAFT; SCINTIGRAPHY; THROMBOSIS;

EID: 0036087155     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2002.123471     Document Type: Article

References (100)

1. Stranger in a strange land: The pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins an arteries
2. Comparison of uptake and degradation of low density lipoproteins by arteries and veins of rabbits
3. Lipid composition in venous arterial bypass grafts
4. Lipid biosynthesis in arteries, veins, and venous grafts
5. Venous response to endothelial denudation
6. Biochemical (functional) adaptation of "arterialized" vein grafts
7. Heterogenous behaviour of the canine arterial and venous wall: Importance of the endothelium
8. Endothelium-dependent contractions in arteries and veins
9. Endothelial regeneration. II Restitution of endothelial continuity
10. Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening
11. Endothelial regeneration. III. Time course of intimal changes after small defined injury to rat aortic endothelium
12. Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation
13. Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein
14. Advanced lesions and acute coronary syndromes: A pathologist's view
15. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization
16. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
17. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: Association of active enzyme synthesis with unstable angina
18. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis
19. Aortocoronary bypass saphenous vein graft atherosclerosis: Anatomic study of 99 vein grafts from normal and hyperlipoproteinemic patients up to 75 months postoperatively
20. Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than 1 year: Necropsy analysis of 53 patients, 123 saphenous veins, and 1865 five-millimeter segments of veins
21. Atherosclerosis in aortocoronary bypass grafts: Morphologic study and risk factor analysis 6 to 12 years after surgery
22. Rapidly progressive arthrosclerosis in aortocoronary saphenous vein grafts: Possible immune-mediated disease
23. Luminal foam cell accumulation is associated with smooth muscle cell death in the intimal thickening of human saphenous vein grafts
24. Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death
25. The identification of active tissue factor in human coronary atheroma
26. Composition of atherosclerotic plaques in the coronary arteries in homozygous familial hypercholesterolemia
27. Composition of atherosclerotic plaques in the four major epicardial coronary arteries in patients ≥ 90 years of age
28. Composition of atherosclerotic plaques in coronary arteries in woman < 40 years of age with fatal coronary artery disease and implications for plaque reversibility
29. Composition of atherosclerotic plaques in the epicardial coronary arteries in juvenile (type I) diabetes mellitus
30. Multiple complex coronary plaques in patients with acute myocardial infarction
31. Aortocoronary saphenous vein graft disease pathogenesis, predisposition, and prevention
32. Fate of venous grafts: The past, the present and the future
33. Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years
34. Antithrombotic therapy for patients with cardiac disease
35. Vein to artery grafts: A morphological and histochemical study of the histogenesis of intimal hyperplasia
36. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression
37. Remodeling of autologous saphenous vein grafts: The role of perivascular myofibroblasts
38. Mammary artery versus saphenous vein grafts: Assessment of basic fibroblast growth factor receptors
39. Endothelial Cell injury in cardiovascular surgery: The intimal hyperplastic response
40. Scanning electron microscopic study of human veins and aorta-coronary artery vein grafts
41. Pathological changes in surgically removed aortocoronary vein grafts
42. Pathologic findings in the aortocoronary vein grafts
43. Atherosclerosis in aortocoronary vein grafts
44. Changes in saphenous vein used as aortocoronary bypass grafts
45. The intimal proliferation in aortic coronary saphenous vein grafts: Light and electron microscopic studies
46. Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than one year: Necropsy analysis of 53 patients, 123 saphenous veins, and 1865 five-millimeter segments of veins
47. Endothelial cell injury in cardiovascular surgery
48. Endothelial cell injury in cardiovascular surgery: Atherosclerosis
49. Absence of focal compensatory enlargement or constriction in diseased human coronary saphenous vein bypass grafts: An intravascular ultrasound study
50. Thrombosed, ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts: Ten years' experience
51. Late thrombosis of saphenous vein coronary bypass grafts related to risk factors
52. Internal-thoracic-artery grafts: Biologically better coronary arteries
53. Stranger in a strange land: The pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between vein sand arteries
54. Percutaneous approaches to recurrent myocardial ischemia in patients with prior surgical revascularization
55. Unstable coronary ischemic syndromes caused by coronary-subclavian steal
56. Microcoil embolization of large intercostal branches of internal mammary artery grafts
57. Usefulness of adjunctive angioscopy and extraction atherectomy before stent implantation in high-risk aortocoronary saphenous vein grafts
58. Evaluation of thrombus removal by transluminal extraction coronary atherectomy by percutaneous coronary angioscopy
59. Atherothrombosis: Mechanisms and clinical therapeutic approaches
60. Coronary plaque disruption
61. Vulnerable plaque. Relation of characteristics to degree of stenosis in human coronary arteries
62. Predicting plaque rupture: Enhancing diagnosis and clinical decision-making in coronary artery disease
63. Late myocardial ischemic events after saphenous vein graft intervention importance of initially "nonsignificant" vein graft lesions
64. Clinical images from intravascular ultrasound: Coronary disease, plaque rupture, and intervention - The inside view
65. Angiographic morphology and the pathogenesis of unstable angina pectoris
66. Parametric (integrated backscatter and attenuation) images constructed using backscattered radio frequency signals (25-56 MHz) from human aortae in vitro
67. Angle dependence of intravascular ultrasound imaging and its feasibility in tissue characterization of human atherosclerotic tissue
68. Comparison of angioscopy intra-vascular ultrasound imaging and quantitative coronary angiography in predicting clinical outcome after coronary intervention in high-risk patients
69. Morphologic comparison of atherosclerotic lesions in native coronary arteries and saphenous vein graphs with in-tracoronary angioscopy in patients with unstable angina
70. Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass surgery
71. Characterization of atherosclerotic plaques by magnetic resonance imaging
72. Acute coronary syndromes: Biology
73. Human coronary atherosclerotic wall imaging using in vivo high resolution MR
74. The human high-risk plaque and its detection by magnetic resonance imaging
75. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: A multicenter study
76. Unstable coronary plaque and its relation to coronary calcium
77. Determinants and correlates of target lesion calcium in coronary artery disease: A clinical, angiographic and intravascular ultrasound study
78. Atherosclerosis: Imaging techniques and the evolving role of nuclear medicine
79. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome
80. Peripheral blood levels of matrix metalloproteinases-2 and -9 are elevated in patients with acute coronary syndromes
81. A platelet-inhibitor drug trial in coronary-artery bypass operations: Benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency
82. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: Results of a Veterans Administration Cooperative Study
83. Prevention of aortocoronary bypass graft occlusion
84. The Post Coronary Artery Bypass Graft Trial Investigators: The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts
85. Long-term graft patency (3 years) after coronary artery surgery: Effects of aspirin: Results of a VA cooperative study
86. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts
87. Regression or stabilization of atherosclerosis means regression or stabilization of what we don't see in the arteriogram
88. Long-Term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts
89. Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wall stents
90. Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts
91. Adenoviral transfection of human saphenous veins with eNOS: Gene therapy applied to coronary bypass conduits
92. Genetic engineering of vein grafts resistant to atherosclerosis
93. Seeding of vascular grafts with genetically modified endothelial cells: Secretion of recombinant TPA results in decreased seeded cell retention in vitro and in vivo
94. S-nitrosoglutathione inhibits coronary artery vein graft platelet activation in vivo
95. Antisense basic FGF (bFGF) gene transfer reduces intimal thickening
96. Local delivery of vascular endothelial growth factor accelerates re-endothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery
97. Local delivery of an anti-tissue factor antibody decreases leukocyte infiltration but fails to limit intimal hyperplasia in experimental vein grafts
98. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor
99. Influence of external stent size on early medical and neointimal thickening in a pig model of saphenous vein bypass grafting